-
L. plantarum P101 Activates AMPK Against Alcoholic Steatosis
2026-09-04
This 2025 mouse study integrated probiotic intervention, AMPK inhibition, gut microbiota profiling, and serum metabolomics to investigate how Lactiplantibacillus plantarum P101 limits alcohol-induced hepatic lipid accumulation. Its pharmacological blockade experiment supports AMPK activation as a mediator while the microbiome and metabolite findings generate testable hypotheses about gut–liver communication.
-
Homoharringtonine: From Ribosomes to Readiness
2026-09-03
Homoharringtonine offers translational researchers a compelling bridge between leukemia research and SARS-CoV-2 antiviral research. Its inhibition of eukaryotic protein synthesis provides a mechanistic rationale for activity across disease models, while recent animal and early patient evidence highlights both its promise and the need for disciplined validation.
-
GPR35–KLF5 Signaling in Epithelial Repair
2026-09-02
A 2026 Cell Death and Disease study identifies a tryptophan metabolic gatekeeping mechanism in which GPR35 senses changes in the tryptophan–kynurenine–kynurenic acid axis and activates KLF5-dependent epithelial repair. The work connects metabolite sensing to PI3K–AKT–mTOR signaling, providing a mechanistic framework for interpreting epithelial proliferation and migration in ulcerative colitis models.
-
Safe DNA Gel Stain for Spermatogenesis Workflows
2026-09-02
Safe DNA Gel Stain combines sensitive green fluorescence with blue-light-compatible imaging for safer DNA and RNA gel analysis. Its flexible in-gel and post-electrophoresis formats support cloning, RNAi validation, and reproductive-biology workflows while helping limit UV-related DNA damage.
-
I-BET151 and the Super-Enhancer Logic of Cancer
2026-09-01
I-BET151, also known as GSK1210151A, offers a pharmacological way to interrogate BET-dependent transcription in cancer biology. This article connects BET bromodomain inhibition with the super-enhancer–FOXA1–SLC7A11 axis described in prostate cancer and outlines a disciplined path from mechanistic hypothesis to translational validation.
-
AIBP-LRP2 Control of Collateral Circulation
2026-09-01
Zhu et al. identify an AIBP-LRP2-HDL-miR-223 pathway that suppresses CXCR4-positive, stemlike capillary endothelial cells during ischemic vascular remodeling. The study supports a two-phase model in which these cells expand before adopting arterial identities, offering a mechanistic framework for therapeutic collateral-vessel growth.
-
Gemcitabine: Mechanism, Evidence, and Workflows
2026-08-31
Gemcitabine is a DNA synthesis inhibitor that creates replication stress and supports cancer research on checkpoint signaling and apoptosis. Product data and a 2025 cholangiocarcinoma study connect its use to cell-based assays, murine models, and chemotherapy-sensitization research.
-
BAPTA-AM: Practical Calcium Chelation Workflow
2026-08-31
BAPTA-AM (SKU B4758) is a cell-permeable calcium chelator for manipulating intracellular Ca²⁺ and investigating calcium-dependent signaling, apoptosis, and cellular stress. It should be treated as an experimental perturbation tool rather than a calcium-specific readout alone, because channel-blocking activity, magnesium interference, solvent effects, and loading variability can affect interpretation.
-
DIDS: Experimental Workflows for Chloride Biology
2026-08-30
DIDS is a versatile anion transport inhibitor for dissecting chloride-channel physiology, TRPV1 signaling, vascular tone, and cell-survival phenotypes. This workflow-focused guide explains how to handle its solubility constraints, build interpretable dose-response experiments, and use the metastasis findings from the reference study without over-attributing effects to chloride blockade.
-
Peptide Tags for Imaging Pseudomonas Phage
2026-08-29
Chan and colleagues isolated a peptide with a conserved LPPIXRX motif that binds the Good Vibes lytic phage infecting Pseudomonas aeruginosa. By coupling the peptide to Cy5 or biotin, the study established a modular strategy for phage detection and tracking that could complement conventional direct-labeling approaches.
-
Palonosetron for Chemotherapy-Induced Nausea and Vomiting
2026-08-28
This review examines why palonosetron may offer clinical advantages over earlier 5-HT3 receptor antagonists, linking its long half-life and distinctive receptor binding to prevention of acute and delayed chemotherapy-induced nausea and vomiting. Its practical message is that pharmacologic innovation matters only when it improves clinically relevant outcomes, especially nausea control, delayed protection, and tolerability.
-
Orientia, RIPK3, and the Limits of Necroptosis Evasion
2026-08-28
This study shows that Orientia tsutsugamushi lowers cellular RIPK3 levels through Ank1 and Ank6 but does not block necroptosis once the RIPK3–MLKL pathway is experimentally activated. The findings distinguish pathogen-mediated reduction of pathway components from true pathway inhibition and provide a useful framework for studying scrub typhus pathogenesis.
-
BMAL1–STAT6 Control of Endothelial Apoptosis
2026-08-27
The reference study identifies BMAL1 as an anti-apoptotic regulator in endothelial cells and links this activity to transcriptional repression of STAT6. Using endothelial-specific genetic manipulation, an alkali-burn corneal neovascularization model, proteomics, rescue experiments, and promoter reporter assays, the authors define a BMAL1–STAT6 regulatory axis with potential relevance to vascular disease research.
-
Safe DNA Gel Stain: Imaging Without UV Trade-Offs
2026-08-27
Safe DNA Gel Stain enables sensitive DNA and RNA gel stain workflows while supporting blue-light visualization and more careful preservation of cloned material. This article connects gel-imaging choices with UV-associated DNA damage mechanisms and defines when the A8743 workflow is scientifically most defensible.
-
Dehydroabietic Acid: PPAR-α/γ Assay Workflow
2026-08-26
Build more informative metabolic assays with Dehydroabietic acid, a dual PPAR-α/γ agonist suited to linking receptor activation with lipid and insulin-response phenotypes. This workflow emphasizes solvent control, orthogonal readouts, and careful interpretation alongside evidence from short-chain lipid metabolism research.